Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML

被引：14

作者：

Cammenga, J ^{[1
]}

机构：

[1] Heinrich Pette Inst Expt Virol & Immunol, Dept Mol Pathol, Hamburg, Germany

来源：

LEUKEMIA | 2005年 / 19卷 / 10期

关键词：

AML; gatekeepers; transcription factors; therapy; hematopoietic stem/progenitor cells;

D O I：

10.1038/sj.leu.2403894

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Acute myelogenous leukemia (AML) is characterized by the accumulation of immature cells due to disturbed differentiation and proliferation of the myeloid lineage. Genetic alterations affecting transcription factors and receptor tyrosine kinases have been identified in AML and causally linked to the disease. The goal of this review is to address the role of the different genetic alterations in self-renewal and proliferation and to discuss the cellular background in which these events occur during the pathogenesis of AML. Data from AML samples, clinical studies and mouse models for AML will be used to support the different theories regarding the leukemogenesis of AML. Finally, this review wants to highlight the implication of these findings for the therapy of AML.

引用

页码：1719 / 1728

页数：10

共 97 条

[51] AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation [J].

Miyamoto, T ;

Weissman, IL ;

Akashi, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7521-7526

[52] Heterozygous PU.1 mutations are associated with acute myeloid leukemia [J].

Mueller, BU ;

Pabst, T ;

Osato, M ;

Asou, N ;

Johansen, LM ;

Minden, MD ;

Behre, G ;

Hiddemann, W ;

Ito, Y ;

Tenen, DG .

BLOOD, 2002, 100 (03) :998-1007

[53] Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells [J].

Müller-Tidow, C ;

Steffen, B ;

Cauvet, T ;

Tickenbrock, L ;

Ji, P ;

Diederichs, S ;

Sargin, B ;

Köhler, G ;

Stelljes, M ;

Puccetti, E ;

Ruthardt, M ;

deVos, S ;

Hiebert, SW ;

Koeffler, HP ;

Berdel, WE ;

Serve, H .

MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :2890-2904

[54] Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element [J].

Mulloy, JC ;

Cammenga, J ;

Berguido, FJ ;

Wu, KD ;

Zhou, P ;

Comenzo, RL ;

Jhanwar, S ;

Moore, MAS ;

Nimer, SD .

BLOOD, 2003, 102 (13) :4369-4376

[55] The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells [J].

Mulloy, JC ;

Cammenga, J ;

MacKenzie, KL ;

Berguido, FJ ;

Moore, MAS ;

Nimer, SD .

BLOOD, 2002, 99 (01) :15-23

[56]

Nakao M, 1996, LEUKEMIA, V10, P1911

[57] Convergence of Wnt, β-catenin, and cadherin pathways [J].

Nelson, WJ ;

Nusse, R .

SCIENCE, 2004, 303 (5663) :1483-1487

[58] C/EBPα mutations in acute myeloid leukaemias [J].

Nerlov, C .

NATURE REVIEWS CANCER, 2004, 4 (05) :394-400

[59]

NEUBAUER A, 1994, BLOOD, V83, P1603

[60] AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis [J].

Okuda, T ;

vanDeursen, J ;

Hiebert, SW ;

Grosveld, G ;

Downing, JR .

CELL, 1996, 84 (02) :321-330

← 1 2 3 4 5 6 7 8 9 10 →